Reeve Emma Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$885,868.84

Insider Activity of Reeve Emma

According to the SEC Form 4 filings, Reeve Emma, being in a position of

  1. director at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18800 shares for $1.45M,
    over all time since 2020-12-14, has bought 0 shares, and sold 75801 share for $5.12M.

Biography of Reeve Emma

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,454,7214100

Comparison of Insiders on Amount of Buys and Sells

2026-01-05SalePTC Therapeutics, Inc.
PTCT
director
734
0.0009%
$76.00$55,784-8.13%
2025-12-03SalePTC Therapeutics, Inc.
PTCT
director
733
0.0009%
$78.62$57,628-6.42%
2025-11-21SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.0126%
$79.50$795,000-9.46%
2025-11-12SalePTC Therapeutics, Inc.
PTCT
director
7,333
0.0095%
$74.50$546,309-4.69%
2025-10-30SalePTC Therapeutics, Inc.
PTCT
director
12,000
0.0157%
$69.50$834,000+5.27%
2025-10-03SalePTC Therapeutics, Inc.
PTCT
director
25,562
0.0346%
$65.96$1.69M+9.74%
2025-09-11SalePTC Therapeutics, Inc.
PTCT
director
4,371
0.0054%
$59.50$260,075+17.62%
2023-05-23SalePTC Therapeutics, Inc.
PTCT
director
2,652
0.0037%
$59.53$157,885-51.16%
2023-05-22SalePTC Therapeutics, Inc.
PTCT
director
7,116
0.0097%
$59.53$423,630-51.73%
2023-04-21SalePTC Therapeutics, Inc.
PTCT
director
4,328
0.0059%
$55.05$238,258-48%
2020-12-14SalePTC Therapeutics, Inc.
PTCT
director
972
0.0015%
$68.00$66,096-35.62%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.